eRelevance’s progressive patient engagement service sold to 100 Medspa, Plastic Surgery practices

NewsGuard 100/100 Score

eRelevance Corporation (www.erelevancecorp.com), announced today that its progressive patient engagement service has been sold to nearly 100 Medical Spa (Medspa) and Plastic Surgery practices in just the first quarter of 2015. The Medspa market in particular, has been growing rapidly and offers a variety of non-invasive anti-aging and weight loss services.

"Our next generation interactive marketing solution is a great fit for Medspas and Plastic Surgery practices," stated Bob Fabbio, co-founder and CEO of eRelevance Corporation. "As a service, we do all of the work to nurture their existing and prospective patients in order to discover their needs, cultivate their interests and drive them in for care. This allows the practice to do what they do best, provide great care to their patients, making us a valued partner."

Unlike traditional impression-based marketing, the eRelevance service uses email, a mobile app, texting, web, and social media to engage existing or prospective patients in automated, personalized conversations to educate, discover needs, cultivate interests, assess health, promote special offers, and learn about their lives. The eRelevance progressive patient engagement service is used by healthcare providers and hospital systems to generate revenue, reduce risks, and improve health.

Source:

eRelevance Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough obesity treatments on the horizon, rivaling surgery's success